Literature DB >> 27922531

Improving Assessments of Population-level Vaccine Impact.

Christian A W Bruhn1, Cynthia Schuck-Paim, Esra Kürüm, Robert J Taylor, Lone Simonsen, Daniel M Weinberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27922531      PMCID： PMC5285271          DOI： 10.1097/EDE.0000000000000598

Source DB:  PubMed          Journal:  Epidemiology        ISSN： 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  34 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Authors:  Shabir A Madhi; Locadiah Kuwanda; Clare Cutland; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2005-04-07       Impact factor: 9.079

3.  Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.

Authors:  Susan Hariri; Michelle L Johnson; Nancy M Bennett; Heidi M Bauer; Ina U Park; Sean Schafer; Linda M Niccolai; Elizabeth R Unger; Lauri E Markowitz
Journal:  Cancer       Date:  2015-06-22       Impact factor: 6.860

4.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

5.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors:  Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129

6.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

7.  Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.

Authors:  Vesta Richardson; Joselito Hernandez-Pichardo; Manjari Quintanar-Solares; Marcelino Esparza-Aguilar; Brian Johnson; Cesar Misael Gomez-Altamirano; Umesh Parashar; Manish Patel
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

8.  Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.

Authors:  Igor Rudan; Katherine L O'Brien; Harish Nair; Li Liu; Evropi Theodoratou; Shamim Qazi; Ivana Lukšić; Christa L Fischer Walker; Robert E Black; Harry Campbell
Journal:  J Glob Health       Date:  2013-06       Impact factor: 4.413

9.  Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.

Authors:  Daniel M Weinberger; Keith P Klugman; Claudia A Steiner; Lone Simonsen; Cécile Viboud
Journal:  PLoS Med       Date:  2015-01-06       Impact factor: 11.069

10.  Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.

Authors:  Eliane Terezinha Afonso; Ruth Minamisava; Ana Luiza Bierrenbach; Juan Jose Cortez Escalante; Airlane Pereira Alencar; Carla Magda Domingues; Otaliba Libanio Morais-Neto; Cristiana Maria Toscano; Ana Lucia Andrade
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883
View more
  5 in total

1.  Filling evidence gaps on the impact of pneumococcal vaccines.

Authors:  Daniel M Weinberger
Journal:  Lancet Infect Dis       Date:  2017-06-07       Impact factor: 25.071

2.  Incorporating Information on Control Diseases Across Space and Time to Improve Estimation of the Population-level Impact of Vaccines.

Authors:  Kayoko Shioda; Jiachen Cai; Joshua L Warren; Daniel M Weinberger
Journal:  Epidemiology       Date:  2021-05-01       Impact factor: 4.860

3.  Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.

Authors:  Parveen Fathima; Mark A Jones; Hannah C Moore; Christopher C Blyth; Robyn A Gibbs; Thomas L Snelling
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

4.  Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries.

Authors:  Kayoko Shioda; Lucia Helena de Oliveira; Jennifer Sanwogou; Gloria Rey-Benito; Diana Nuñez Azzad; Roxana Elizabeth Castillo; María Liz Gamarra Ramírez; Marta Raquel Von Horoch; Daniel M Weinberger; Virginia E Pitzer
Journal:  Vaccine       Date:  2019-10-28       Impact factor: 4.169

Review 5.  PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).

Authors:  Christian Theilacker; Mark A Fletcher; Luis Jodar; Bradford D Gessner
Journal:  Microorganisms       Date:  2022-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.